{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:11:15Z","timestamp":1790838675351,"version":"4.1.0"},"reference-count":37,"publisher":"Impact Journals, LLC","issue":"25","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,6,20]]},"DOI":"10.18632\/oncotarget.17254","type":"journal-article","created":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T01:34:27Z","timestamp":1492652067000},"page":"40804-40816","source":"Crossref","is-referenced-by-count":22,"title":["Inhibiting translesion DNA synthesis as an approach to combat drug resistance to DNA damaging agents"],"prefix":"10.18632","volume":"8","author":[{"given":"Jung-Suk","family":"Choi","sequence":"first","affiliation":[{"name":"Department of Chemistry, Cleveland State University, Cleveland, OH 44115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seol","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Biological, Geological, and Environmental Sciences, Cleveland State University, Cleveland, OH 44115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Motea","sequence":"additional","affiliation":[{"name":"Departments of Radiation Oncology and Pharmacology, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Berdis","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Cleveland State University, Cleveland, OH 44115, USA"},{"name":"Department of Biological, Geological, and Environmental Sciences, Cleveland State University, Cleveland, OH 44115, USA"},{"name":"Center for Gene Regulation in Health and Disease, Cleveland State University, Cleveland, OH 44115, USA"},{"name":"Case Comprehensive Cancer Center, Cleveland, OH 44106, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,4,19]]},"reference":[{"key":"1","first-page":"107","article-title":"DNA damage tolerance: a double-edged sword guarding the genome","volume":"2","author":"Chen","year":"2013","journal-title":"Translational cancer research"},{"key":"2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/35040051","article-title":"The expanding polymerase universe","volume":"1","author":"Tippin","year":"2000","journal-title":"Nature reviews molecular cell biology"},{"key":"3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/cr.2008.4","article-title":"The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases","volume":"18","author":"Kunkel","year":"2008","journal-title":"Cell research"},{"key":"4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nrc2998","article-title":"DNA polymerases and cancer","volume":"11","author":"Wood","year":"2011","journal-title":"Nature reviews cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1089\/ars.2010.3673","article-title":"DNA polymerase eta and chemotherapeutic agents","volume":"14","author":"Chou","year":"2011","journal-title":"Antioxidants & redox signaling"},{"key":"6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-90-481-3471-7_10","article-title":"DNA polymerase eta, a key protein in translesion synthesis in human cells","volume":"50","author":"Carty","year":"2010","journal-title":"Subcellular biochemistry"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Xie, Doles, Hemann, Walker. Error-prone translesion synthesis mediates acquired chemoresistance. Proceedings of the national academy of science of the united states of america. 2010; 107:pp. 20792\u201320797.","DOI":"10.1073\/pnas.1011412107"},{"key":"8","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: mode of cytotoxic action and molecular basis of resistance","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"key":"9","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1158\/0008-5472.CAN-14-0953","article-title":"Translesion polymerase \u03b7 is upregulated by cancer therapeutics and confers anticancer drug resistance","volume":"74","author":"Christmann","year":"2014","journal-title":"Cancer research"},{"key":"10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.1239947","article-title":"Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma","volume":"343","author":"Nelson","year":"2014","journal-title":"Science"},{"key":"11","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/nrc1749","article-title":"Mechanisms of therapy-related carcinogenesis","volume":"5","author":"Travis","year":"2005","journal-title":"Nature reviews cancer"},{"key":"12","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/pro.2554","article-title":"Uracil-DNA glycosylases-structural and functional perspectives on an essential family of DNA repair enzymes","volume":"23","author":"Chattopadhyay","year":"2014","journal-title":"Protein science"},{"key":"13","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1093\/nar\/gkr980","article-title":"Development of a \u2018clickable\u2019 non-natural nucleotide to visualize the replication of non-instructional DNA lesions","volume":"40","author":"Berdis","year":"2012","journal-title":"Nucleic acids research"},{"key":"14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.mrgentox.2005.10.005","article-title":"Improved measurement of dibenzo[a, l]pyrene-induced abasic sites by the aldehyde-reactive probe assay","volume":"588","author":"Cavalieri","year":"2005","journal-title":"Mutation research"},{"key":"15","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1021\/cb300038f","article-title":"A non-natural nucleoside with combined therapeutic and diagnostic activities against leukemia","volume":"7","author":"Berdis","year":"2012","journal-title":"ACS chemical biology"},{"key":"16","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/em.20573","article-title":"Translesion DNA synthesis polymerases in DNA interstrand crosslink repair","volume":"51","author":"Sch\u00e4rer","year":"2010","journal-title":"Environmental and molecular mutagenesis"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Srivastava, Han, Zhao, Cui, Dai, Mao, Zhao, Zhang, Yu, Wang. Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells. Proceedings of the national academy of science of the united states of america. 2015; 112:pp. 4411\u20134416.","DOI":"10.1073\/pnas.1421365112"},{"key":"18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.phrs.2007.08.003","article-title":"Triazene compounds: mechanism of action and related DNA repair systems","volume":"56","author":"De Vecchis","year":"2007","journal-title":"Pharmacological research"},{"key":"19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Tchounwou","year":"2014","journal-title":"European journal of pharmacology"},{"key":"20","first-page":"187","article-title":"Chlorambucil in chronic lymphocytic leukemia: mechanism of action","volume":"23","author":"Johnston","journal-title":"Leukemia & Lymphoma"},{"key":"21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0165-1110(94)90015-9","article-title":"DNA damage and mutagenesis induced by nitrogen mustards","volume":"318","author":"Shuker","year":"1994","journal-title":"Mutation research"},{"key":"22","first-page":"84","article-title":"DNA torsion, and chromatin dynamics","volume":"1845","author":"Doxorubicin","year":"2014","journal-title":"Biochimica et biophysica acta"},{"key":"23","doi-asserted-by":"crossref","first-page":"510","DOI":"10.4103\/0973-1482.106526","article-title":"Antimetabolites: established cancer therapy","volume":"8","author":"Tiwari","year":"2012","journal-title":"Journal of cancer research therapeutics"},{"key":"24","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.tips.2006.06.004","article-title":"Nucleoside transporters: from scavengers to novel therapeutic targets","volume":"27","author":"Baldwin","year":"2006","journal-title":"Trends in pharmacological sciences"},{"issue":"Suppl 1","key":"25","first-page":"26","article-title":"Nucleoside transport and associated metabolism","volume":"12","author":"Ekkehard Neuhaus","year":"2010","journal-title":"Plant biology (Stuttg)"},{"key":"26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.tibs.2008.02.004","article-title":"Lesion processing: high-fidelity versus lesion-bypass DNA polymerases","volume":"33","author":"Patel","year":"2008","journal-title":"Trends biochemical Sciences"},{"key":"27","doi-asserted-by":"crossref","first-page":"729","DOI":"10.4161\/cc.9.4.10727","article-title":"Multiple two-polymerase mechanisms in mammalian translesion DNA synthesis","volume":"9","author":"Shachar","year":"2010","journal-title":"Cell Cycle"},{"key":"28","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1158\/1078-0432.CCR-08-1227","article-title":"Polymerase eta mRNA expression predicts survival of non-small cell lung cancer patients treated with platinum-based chemotherapy","volume":"15","author":"Scagliotti","year":"2009","journal-title":"Clinical cancer research"},{"key":"29","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s12013-014-0046-x","article-title":"Association of POLK polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patients","volume":"70","author":"Han","year":"2014","journal-title":"Cell biochemistry biophysics"},{"key":"30","doi-asserted-by":"crossref","first-page":"e83978","DOI":"10.1371\/journal.pone.0083978","article-title":"Expression of DNA translesion synthesis polymerase \u03b7 in head and neck squamous cell cancer predicts resistance to gemcitabine and cisplatin-based chemotherapy","volume":"8","author":"Km","year":"2013","journal-title":"PLoS one"},{"key":"31","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1158\/0008-5472.CAN-04-0603","article-title":"Altered DNA polymerase iota expression in breast cancer cells leads to a reduction in DNA replication fidelity and a higher rate of mutagenesis","volume":"64","author":"Malkas","year":"2004","journal-title":"Cancer research"},{"key":"32","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/neuonc\/nop074","article-title":"Analysis of specialized DNA polymerases expression in human gliomas: association with prognostic significance","volume":"12","author":"Lu","year":"2010","journal-title":"Neuro-oncology"},{"key":"33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.canlet.2004.07.021","article-title":"Down-regulation of DNA polymerases kappa, eta, iota, and zeta in human lung, stomach, and colorectal cancers","volume":"217","author":"Hu","year":"2005","journal-title":"Cancer letters"},{"key":"34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jgo.2014.04.002","article-title":"Potential drug interactions and chemotoxicity in older patients with cancer receiving chemotherapy","volume":"5","author":"Balducci","year":"2014","journal-title":"Journal of geriatric oncology"},{"key":"35","doi-asserted-by":"crossref","first-page":"38442","DOI":"10.1074\/jbc.M112.404319","article-title":"The human lagging strand DNA polymerase \u03b4 holoenzyme is distributive","volume":"287","author":"Benkovic","year":"2012","journal-title":"Journal of Biological Chemistry"},{"key":"36","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1093\/nar\/gkh777","article-title":"Enzymatic switching for efficient and accurate translesion DNA replication","volume":"32","author":"Kunkel","year":"2004","journal-title":"Nucleic Acids Research"},{"key":"37","doi-asserted-by":"crossref","first-page":"13293","DOI":"10.1021\/bi060418v","article-title":"Rational attempts to optimize non-natural nucleotides for selective incorporation opposite an abasic site","volume":"45","author":"Berdis","year":"2006","journal-title":"Biochemistry"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17254","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T17:32:47Z","timestamp":1719163967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,19]]},"references-count":37,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2017,6,20]]}},"alternative-id":["17254","28489578"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.17254","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,19]]}}}